Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 23:00:57 - browse：546

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Teladoc has a new CEO, but challenges remain the same

WSS

J&J to emphasize cancer drugs, stop much of its vaccine research

ALS patient reclaims some autonomy thanks to wearable 'robot'

Organ aging and disease risk measured by new blood test

The system is set up to fail children with medical complexity

Moderna says combo Covid

What don’t we know about an Alzheimer’s drug side effect?

hotspot

Wikipedia

focus

Peter Hotez and the public health issue of online harassment

Curing rare childhood diseases will falter unless Congress steps up

The high cost of giving birth even with insurance

Readers discuss the intersection of pregnancy and addiction

Hollywood unions extend contract negotiations for actors

Pediatric cancer treatments threatened by a new FDA policy

23andMe had bad news about my health. I wish a person had delivered it

What don’t we know about an Alzheimer’s drug side effect?

How one medical school became remarkably diverse

Deposition: Sackler embraced plan to conceal OxyContin’s strength

knowledge

Pharma companies must ensure equitable access to obesity drugs

U.K. Biobank has 500,000 peoples' genome sequences available

The EPA's new lead rule: How one expert crunched the numbers

UnitedHealth’s Optum accused of antitrust violations in California

California wildfire smoke linked to 52,000 early deaths, study says

Fetal surgery at risk from Dobbs and new abortion restrictions

knowledge

explore

hotspot

hotspot